mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.04 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.04 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |